These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3290887)

  • 61. [Control over treatment efficacy in pulmonary tuberculosis patients by determining the amount of nucleic acids in the blood].
    Safarian MD; Varosian MA; Karapetian ET
    Vrach Delo; 1990 Dec; (12):42-4. PubMed ID: 1708561
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 63. [3d study by the African and British Medical Research Councils of short term chemotherapy (including relapse rates during 18 months following chemotherapy)].
    Swai OB
    Bull Int Union Tuberc; 1978 Dec; 53(4):254-5. PubMed ID: 387137
    [No Abstract]   [Full Text] [Related]  

  • 64. [Enhancing the effectiveness of chemotherapy for pulmonary tuberculosis by phytotherapy in patients with different genetic markers].
    Tashpulatova FK; Ubaĭdullaev AM
    Probl Tuberk; 2002; (12):46-9. PubMed ID: 12611337
    [No Abstract]   [Full Text] [Related]  

  • 65. [Clinical experimentation of 4-4-diisoamyloxythiocarbanilide in the treatment of pulmonary tuberculosis].
    Jacometta Longarato F; Belleni C; Paolucci G
    Friuli Med; 1964; 19(6):935-49. PubMed ID: 5318307
    [No Abstract]   [Full Text] [Related]  

  • 66. [Problems in the treatment of patients with pulmonary tuberculosis].
    Chukanov VI
    Probl Tuberk; 1997; (4):17-9. PubMed ID: 9333807
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Tolerance for antitubercular preparations in the tuberculosis treatment of children and adolescents].
    Firsova VA; Mart'ianova EP
    Probl Tuberk; 1980 Oct; (10):47-51. PubMed ID: 7433447
    [No Abstract]   [Full Text] [Related]  

  • 68. [Results of controlled therapeutic trials. II. Intermittent regimens. Conclusion].
    Sunahara S
    Bull Int Union Tuberc; 1974; 49(1):456-7. PubMed ID: 4619568
    [No Abstract]   [Full Text] [Related]  

  • 69. Basic concepts in the treatment of tuberculosis.
    Swaminathan S
    Indian J Pediatr; 2002 Nov; 69 Suppl 1():S44-9. PubMed ID: 12501925
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Results of treatment of patients with recurrent pulmonary tuberculosis].
    Gorak AG
    Probl Tuberk; 1985; (3):6-9. PubMed ID: 4011593
    [No Abstract]   [Full Text] [Related]  

  • 71. Chemotherapy of tuberculosis under routine conditions in Czechoslovakia.
    Danková D
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):182-6. PubMed ID: 2999962
    [No Abstract]   [Full Text] [Related]  

  • 72. [Lipoprotein metabolic study of pulmonary tuberculosis during antibacterial treatment].
    Liudvichek IA
    Probl Tuberk; 1982 Sep; (9):67-71. PubMed ID: 7145922
    [No Abstract]   [Full Text] [Related]  

  • 73. [Liver function and antitubercular agents. Results of a polycentric study with various chemo-antibiotic combinations].
    Grassi C; Mainardi L; Pasquariello G; Bissanti A; Luvarà A; Pozzi E
    G Ital Chemioter; 1973; 20(1-4):1-14. PubMed ID: 4619078
    [No Abstract]   [Full Text] [Related]  

  • 74. [Clinical research on the use of morphazinamide in pulmonary tuberculosis].
    Jancík E
    Minerva Med; 1965 Sep; 56(71):2905-10. PubMed ID: 5322274
    [No Abstract]   [Full Text] [Related]  

  • 75. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 76. [Results of different programs of chemotherapy using rifampicin in patients with newly detected destructive pulmonary tuberculosis].
    Sodikov ES; Abrarov BA
    Probl Tuberk; 1986; (5):27-30. PubMed ID: 3526322
    [No Abstract]   [Full Text] [Related]  

  • 77. [Combined use of various secondary antitubercular agents].
    Kekkaku; 1968 Mar; 43(3):45-7. PubMed ID: 4877917
    [No Abstract]   [Full Text] [Related]  

  • 78. Trial of immunopotentiation by levamisole in patients with pulmonary tuberculosis.
    Yaseen NY; Thewaini AJ; Al-Tawil NG; Jazrawi FY
    J Infect; 1980 Jun; 2(2):125-36. PubMed ID: 6985257
    [No Abstract]   [Full Text] [Related]  

  • 79. [Treatment of pulmonary tuberculosis in patients with drug dependence].
    Zadremaĭlova TA; Aksenova KI
    Probl Tuberk Bolezn Legk; 2003; (7):31-3. PubMed ID: 12939874
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Compliance with antitubercular chemotherapy, a central element in the efficacy of a national program].
    Corlan E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):187-91. PubMed ID: 2555908
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.